---
figid: PMC9685224__mmr-27-01-12898-g06
figtitle: Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin
  is mediated by targeting the Akt signaling pathway and activating the Hippo signaling
  pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9685224
filename: mmr-27-01-12898-g06.jpg
figlink: /pmc/articles/PMC9685224/figure/f7-mmr-27-01-12898/
number: F7
caption: Schematic diagram. Combination treatment of UA + DOX results in tumorigenesis
  inhibition, mediated by targeting Akt/Gsk3β signaling and activating tumor-suppressive
  Hippo signaling, thereby inducing degradation of p-Yap in CRC cells. Combination
  of UA + DOX therapy reduced proliferation and promoted apoptosis in CRC cells by
  activating Akt-mediated effects of the mitochondrial pathway. Following combined
  UA + DOX treatment, LY294002 further inhibited Akt activity activating Hippo signaling
  pathway. Mob1, MOB kinase activator 1; Mst, mammalian Ste20-like kinases; CTGF,
  connective tissue growth factor; Sav1, salvador family WW domain containing protein
  1; Rassf1A, Ras association domain family member 1; p, phosphorylated; Gsk3β, glycogen
  synthase kinase-3β; PARP, poly(ADP-ribose) polymerase 1; UA, ursolic acid; DOX,
  doxorubicin.
papertitle: Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin
  is mediated by targeting the Akt signaling pathway and activating the Hippo signaling
  pathway.
reftext: Dan Hu, et al. Mol Med Rep. 2023 Jan;27(1):11.
year: '2023'
doi: 10.3892/mmr.2022.12898
journal_title: Molecular Medicine Reports
journal_nlm_ta: Mol Med Rep
publisher_name: D.A. Spandidos
keywords: ursolic acid | doxorubicin | colorectal cancer cells | Akt | Hippo signaling
  pathway | yes-associated protein 1
automl_pathway: 0.9408351
figid_alias: PMC9685224__F7
figtype: Figure
redirect_from: /figures/PMC9685224__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9685224__mmr-27-01-12898-g06.html
  '@type': Dataset
  description: Schematic diagram. Combination treatment of UA + DOX results in tumorigenesis
    inhibition, mediated by targeting Akt/Gsk3β signaling and activating tumor-suppressive
    Hippo signaling, thereby inducing degradation of p-Yap in CRC cells. Combination
    of UA + DOX therapy reduced proliferation and promoted apoptosis in CRC cells
    by activating Akt-mediated effects of the mitochondrial pathway. Following combined
    UA + DOX treatment, LY294002 further inhibited Akt activity activating Hippo signaling
    pathway. Mob1, MOB kinase activator 1; Mst, mammalian Ste20-like kinases; CTGF,
    connective tissue growth factor; Sav1, salvador family WW domain containing protein
    1; Rassf1A, Ras association domain family member 1; p, phosphorylated; Gsk3β,
    glycogen synthase kinase-3β; PARP, poly(ADP-ribose) polymerase 1; UA, ursolic
    acid; DOX, doxorubicin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - yki
  - Rassf
  - sav
  - mst
  - hpo
  - Mst84Dd
  - Mst84Dc
  - Mst84Db
  - Mst84Da
  - CG12279
  - Mst87F
  - Mst98Cb
  - Mst98Ca
  - mats
  - Rpn3
  - Dox-3
  - Akt
  - sgg
  - Axn
  - gskt
  - Myc
  - Parp
  - YAP1
  - RASSF1
  - RASSF2
  - RASSF3
  - RASSF4
  - RASSF5
  - RASSF6
  - RASSF7
  - RASSF8
  - RASSF9
  - RASSF10
  - SAV1
  - MAP3K10
  - MPST
  - TAM
  - MSTO1
  - SGMS1
  - MOB2
  - MOB3A
  - MOB3B
  - MOB3C
  - MOB4
  - MOB1A
  - MOB1B
  - CCN2
  - AKT1
  - AKT2
  - AKT3
  - GSK3B
  - MYC
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - DOX
  - LY 294002
---
